TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 40 filers reported holding TAYSHA GENE THERAPIES INC in Q2 2023. The put-call ratio across all filers is 0.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $493,908 | +378.1% | 156,300 | 0.0% | 0.01% | +500.0% |
| Q2 2023 | $103,314 | -17.1% | 156,300 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $124,665 | -47.4% | 156,300 | +49.0% | 0.00% | -50.0% |
| Q4 2022 | $237,004 | -12.2% | 104,869 | -25.0% | 0.01% | -14.3% |
| Q3 2022 | $270,000 | +2.7% | 139,869 | +97.5% | 0.01% | +16.7% |
| Q2 2022 | $263,000 | – | 70,809 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Capital Investment Advisors, LLC | 10,000 | $17,700 | 0.00% |